During early embryogenesis, the ectoderm is rapidly subdivided into neural, neural crest and sensory 2 progenitors. How the onset of lineage-specific determinants and the loss of pluripotency markers 3 are temporally and spatially coordinated in vivo remains an open question. Here we identify a critical 4 role for the transcription factor PRDM1 in the orderly transition from epiblast to defined neural 5 lineages. Like pluripotency factors, PRDM1 is expressed in all epiblast cells prior to gastrulation, but 6 lost as they begin to differentiate. We show that, unlike pluripotency factors, PRDM1 is initially 7 required for the activation of neural, neural crest and sensory progenitor specifiers and for the 8 downregulation of pluripotency-associated genes. In vivo chromatin immunoprecipitation reveals 9 stage-specific binding of PRDM1 to regulatory regions of neural and sensory progenitor genes, 10
INTRODUCTION 1
In human and mouse embryonic stem cells, exit from pluripotency and entry into differentiation Monsoro-Burq, 2018; Streit, 2018) . The definitive neural plate, the primordium for the central 26 border genes like Dlx5/6, Msx2 and TFAP2a/e and transcripts expressed in a subset of sensory 11
progenitors (e.g. Pax6, SSTR5, Dmbx1) (Supplemental Table 2 ). To assess whether PRDM1 occupies 12 these sites in vivo, we focused on Sox2 and Eya2 as key factors required for neural plate and sensory 13 progenitor specification and performed PRDM1 chromatin immunoprecipitation (ChIP) followed by 14 qPCR (Fig. 3A-D ChIP-qPCR reveals a significant enrichment of PRDM1 upstream of the Sox2 and Eya2 TSS when 19 compared to IgG controls, but only in early neural plate and sensory progenitor cells, respectively (Fig.  20 3C, D). As a negative control we examined the TSS of the histone demethylase Kdm4a, which is 21 ubiquitously expressed in epiblast cells at all the stages tested (Strobl-Mazzulla et al., 2010) and lacks 22 a PRDM1 motif. We do not observe PRDM1 binding (Fig. 3I) Although PRDM1 is expressed in all four cell populations tested, it binds close to the Sox2 and Eya2 4 TSS in a stage-and tissue-specific manner. We reasoned that changes in chromatin accessibility, DNA 5 methylation and/or repressive histone marks may be important for the regulation of neural and 6 sensory progenitor gene expression and for PRDM1 binding. To assess these features as cells become 7 successively specified we dissected pre-streak epiblast, neural plate and sensory progenitor cells. To 8 investigate chromatin accessibility we performed ATAC-qPCR probing the genomic regions upstream 9 of the Sox2 and Eya2 TSS that harbour PRDM1 motifs and determined accessibility in neural plate and 10 sensory progenitors relative to pre-streak epiblast cells. This analysis reveals that the PRDM1 site 11 upstream of the Sox2 TSS opens in neural plate cells at HH4 -, while that upstream of the Eya2 TSS 12 becomes accessible only in sensory progenitors at HH5/6 (Fig. 3E) . Thus, changes in chromatin 13 accessibility coincide with the onset of Sox2 and Eya2 expression and with PRDM1 occupancy. 14 Methylation of CpG islands in proximity of the TSS is generally associated with transcriptional 15 repression, and PRDM1 binding is known to be methylation sensitive (Doody et al., 2010). Indeed, CpG 16 islands are predicted at position -2kb to -0.4kb from the Sox2 and -2kb to -1.7kb from the Eya2 TSS 17 close to PRDM1 binding sites. To investigate CpG methylation we performed bisulphite assays, where 18 cytosine is converted into uracil, while 5-methylcytosine remains intact, in pre-streak epiblast, neural 19 plate and sensory progenitor cells. The above genomic regions were probed by PCR using primers 20 specific for methylated and non-methylated DNA. We find that at pre-streak stages, Sox2 is not 21 methylated, while CpG islands upstream of the Eya2 TSS are, but their methylation is lost in sensory 22 progenitors (Fig. 3F) H3K9me3 later in HH5/6 sensory progenitors (Fig. 3G, H) . To ensure specificity we used the 6 ubiquitously expressed Kdm4a as control; we do not observe any changes in H3K9me3 (Fig 3J) . Thus, 7
histone demethylation at the TSS of Sox2 and Eya2 clearly reflects the time and tissue specific 8 transcriptional status of both genes. immunoprecipitation reveals that PRDM1 and Kdm4a bind to each other (Fig. 3M ). We next examined 10 whether Kdm4a is located close to the Sox2 and Eya2 TSS using ChIP qPCR. In pre-streak epiblast, 11
Kdm4a does not occupy either region, but binds close to the Sox2 TSS in early neural plate cells and 12
close to the Eya2 TSS in sensory progenitor cells (Fig. 3N, O) . Thus, both PRDM1 and Kdm4a are found 13 close to the TSS of Sox2 and Eya2 when their transcription becomes activated. 14 Is PRDM1 required for Kdm4a binding? To test this, we knocked down PRDM1 in neural and sensory 15 progenitors by electroporation of aONs at HH3 and collected both tissues at HH4 -and HH6, 16 respectively. Kdm4a ChIP-qPRC reveals that in the absence of PRDM1, Kdm4a binding to both genomic 17 regions is lost (Fig. 3N, O) . These results show that PRDM1 is required to recruit Kdm4a to the TSS of 18
Sox2 and Eya2. 19
Together our results provide a model for sequential specification of neural and sensory progenitor 20 fates in the embryonic ectoderm, with PRDM1 as a central player (Fig. 4) . Prior to activation of cell 21 type specific transcripts their TSSs are inaccessible and decorated with repressive marks like 22
H3K9me3. As they become accessible, PRDM1 binds upstream of the TSS of key neural and sensory 23
progenitor genes, recruits the histone demethylase Kdm4a, which in turn demethylates H3K9me3 to 24 facilitate transcriptional activation. 25
During embryo development, exit from pluripotency and sequential activation of distinct 2 differentiation programmes must tightly controlled to coordinate cell fate decisions with 3 morphogenetic processes. Our findings place the transcription factor PRDM1 into the centre of the 4 network regulating these processes in the embryonic ectoderm. Dissection of PRDM1 function in time 5
and space allows us to distinguish different PRDM1 activities. Initially, PRDM1 is required for cells to 6 lose pluripotency markers, and at the same time for activating the neural, neural crest and sensory 7 progenitor programme. Once cells are specified PRDM1 must be downregulated rapidly to maintain 8 these fates: prolonged expression prevents the differentiation of neural lineages. Thus, PRDM1 9 function changes rapidly presumably due to interaction with different co-factors. repressive marks at the promoter region suggesting that both mechanisms work in concert to activate 23
Sox2 transcription in early neural plate cells. It is tempting to speculate that a similar mechanism acts 24 to promote the transcription of neural plate border, neural crest and sensory progenitor genes. Our 25 analysis shows that the neural plate border genes Dlx5/6, Gata3, TFAPa/e and Msx2 harbour PRDM1 1 motifs close to their TSS, as do Six1 and Eya2, and the neural crest factor Foxd3, suggesting that 2 PRDM1 may indeed control the onset of their expression directly recruiting Kdm4a to remove 3 repressive histone marks. Whether Geminin, ERNI and BERT at enhancer regions cooperate with 4 PRDM1 as described for Sox2 remains to be elucidated. Together, these observations place PRDM1 5 into the centre of the transcriptional network controlling the onset of neural, neural crest and sensory 6 progenitor specification. During embryo development, exit from pluripotency and sequential activation of distinct 2 differentiation programmes must tightly controlled in time and space to coordinate cell fate decisions 3 with morphogenetic processes. PRDM1 emerges as a key node in the network regulating these 4 processes in the embryonic ectoderm (Fig. 4) . PRDM1 is required for cells to lose pluripotency 5 markers, while at the same time activating the neural, neural crest and sensory progenitor 6 programme. Once initiated PRDM1 must be downregulated rapidly to allow central and peripheral 7 nervous system precursors to maintain their identity. Thus, PRDM1 is a versatile factor which works 8 both as transcriptional activator or repressor in a time dependent manner to control fate decisions. In 9 embryonic stem cells and primordial germ cells, PRDM1 downstream targets have been extensively 10 characterised and are partially overlapping. It will be interesting to evaluate how these networks 11 diverge in the neural lineage. 12 
13

MATERIALS AND METHODS 14
Embryo collection and whole mount in situ hybridization 15 border and early neural plate, and HH6 sensory progenitors were dissected in Tyrode's saline. Tissues 7 were homogenized in nuclear extraction buffer (NEB: 0.5% NP-40, 0.25% TritonX-100, 10mM Tris-HCl 8 pH7.5, 3mM CaCl2, 0.25M Sucrose, 1mM DDT, 0.2mM PMSF, 1x Protease Inhibitor (PI)) using a Dounce 9 homogenizer and fixed with 0.9% formaldehyde for 10 min at room temperature. The fixing reaction 10 was quenched with 125mM glycine, the tissues were washed three times in PSB-PI (1mM DDT, 0.2mM 11 PMSF, 1x PIS). Cells were re-suspended in NEB and nuclei were released by Dounce homogenizing 12 using a tight pestle. Nuclei were washed with PSB-PI and lysed in SDS lysis buffer (1% SDS, 10mM EDTA 13 in 50mM Tris-HCl pH8) for 1 hour on ice before being diluted to 0.9ml with ChIP Dilution Buffer (CDB: 14 0.01%SDS, 1.2mM EDTA, 167mM NaCl, 1mM DDT, 0.2mM PMSF and 1x PI in 16.7mM Tris-HCl, pH8) 15 and sonicated to obtain 500-1000 bp chromatin fragments. TritonX-100 was added to a final 16 concentration of 1% before the chromatin was used for ChIP. Protein-A magnetic beads (100ul) were 17 blocked with 0.5% BSA and coated with the 5mg antibody (Abcam; PRDM1 ab13700; H3K9me3 18 ab8898; control IgG 5mg) before being added to the chromatin and allowed to bind overnight at 4°C. 19
Beads were washed six times with RIPA buffer (500mM LiCl, 1mM EDTA, 1%NP-40, 0.7% Na-20 deoxycholate, 1x PI in 50mM HEPES-KOH, pH8), followed by three washes in 10mM Tris-HCl, pH8 21 containing 1mM EDTA and 50mM NaCl. Chromatin was released from the beads in elution buffer 22 (10mM EDTA, 1%SDS in 50mM Tris-HCl, pH8) at 65°C for 30 minutes. The eluted chromatin was reverse 23 cross-linked by incubating 65°C for overnight before being incubated with RNaseA (0.2mg/ml) and 24
Proteinase K(0.2mg/ml). DNA was purified using phenol-chloroform and assayed with qPCR using 25 20 primers for different genomic regions flanking PRDM1 morida (see Supplemental Table 3 ). The 1 genomic region -2kb from the TSS of each gene was extracted from GalGal6 and screened for PRDM1 2 motifs using RSAT (rsat.sb-roscoff.fr). The PRDM1 matrix obtained from JASPER (jaspar.genereg.net). 3 4
Western blot and co-immunoprecipitation 5
For western blot, 50 HH4-6 neural plate border / sensory progenitor tissues we lysed in SDS-PAGE 6 loading buffer by heating to 100°C for 10min. The lysate was separated using 10% SDS-PAGE and 7
proteins were transferred to immuno-blot PVDF membrane. Blots were blocked with 5% milk powder 8 in PBS for 1 hour at room temperature, followed by incubation with primary antibodies to PRDM1 9 To assess the accessibility of the chromatin upstream of the Sox2 and Eya2 TSSs we performed ATAC 22 qPCR from sensory progenitors, neural plate and pre-streak epiblast. 15 sensory progenitor and neural 23 plate explants (HH6) and two central pre-streak epiblast pieces (about 10,000 cells each) were used 24 for each experiment. Tissues were dissociated and nuclei were isolated in cold lysis buffer (10mM 25 NaCl, 3mM Mgcl2, 0.1% IPGEPAL CA-630 in 10mM Tris-HCL, pH7.4). Nuclei were washed with lysis 1 buffer, recovered by centrifugation at 500xg and treated with transposase (Tn5 Transposase, Illumina, 2 FC-121-1030) for 10min as described by Buenrostro and colleagues (Buenrostro et al., 2013). DNA was 3 purified using a mini-elute PCR purification kit (QIAGEN) and qPCR was performed using primers for 4 the region upstream of the Sox2 and Eya2 TSS. 5 6
DNA methylation assay 7
To examine the methylation status CpG islands were predicted within 2kb upstream of upstream of 8 the Sox2 and Eya2 TSS using MethPrimer (Li and Dahiya, 2002). Central pre-streak epiblast, early 9 neural plate (HH4 -) and sensory progenitors (HH6) were dissected and genomic DNA was prepared 10 using the DNeasy blood & tissue kit from Qiagen (69504). Genomic DNA was treated with bisulfide to 11 convert unmethylated cytosine to uracil using Thermo Scientific EpiJET Bisulfide Conversion Kit (Fisher 12 Scientific, K1461) and used for PCR using two pairs of primers for the region upstream the TSS of Sox2 13 and Eya2 that that flank the PRDM1 motif and amplify either methylated or unmethylated DNA. PCR 14 was carried out using Phusion U Hot Start DNA Polymerase (Fisher Scientific F-555S/L) and analysed 15 by gel electrophoresis. 16 
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